The company and all members of the board guarantee that the information disclosed is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
Overview of the Impairment Provision
(1) Reason for the Impairment Provision
To accurately reflect the financial condition, asset value, and operating status of Shanghai Zhenlan Instrument Technology Co., Ltd. (hereinafter referred to as "the Company"), and in accordance with the relevant provisions of the "Enterprise Accounting Standards" and the Company's accounting policies, the Company conducted a comprehensive review of various assets within the scope of the consolidated financial statements as of December 31, 2025. This included notes receivable, accounts receivable, other receivables, contract assets, long-term receivables, inventory, long-term equity investments, fixed assets, construction in progress, intangible assets, and goodwill. After thorough evaluation and analysis, it was determined that certain assets showed signs of impairment, leading to the recognition of an impairment provision.
(2) Scope and Total Amount of the Impairment Provision
The Company recognized an impairment provision totaling 52.4612 million yuan for the relevant assets in 2025, detailed as follows:
| Asset Impairment Item | Amount (yuan) |
|---|---|
| Credit impairment loss | |
| Accounts receivable - Bad debt provision | 15,515,358.31 |
| Other receivables - Bad debt provision | 5,487,254.18 |
| Notes receivable - Bad debt provision | 2,578,973.74 |
| Long-term receivables - Bad debt provision | 1,276,300.45 |
| Subtotal | 24,857,886.68 |
| Inventory impairment provision | 16,965,204.90 |
| Goodwill impairment provision | 6,414,966.74 |
| Contract assets impairment provision | 4,223,139.39 |
| Subtotal | 27,603,311.03 |
| Total | 52,461,197.71 |
Note: The above impairment provision data has been audited by an accounting firm.
(3) Approval Procedure for the Impairment Provision
According to the "Shenzhen Stock Exchange GEM Stock Listing Rules" and other relevant laws, regulations, and normative documents, as well as the Company's Articles of Association, this impairment provision does not require submission for approval by the Company's board of directors or shareholders' meeting.
Confirmation Standards and Methods for the Impairment Provision
(1) Determination Method for Financial Instrument Impairment
The Company recognizes loss provisions based on expected credit losses for financial assets measured at amortized cost, debt investments measured at fair value with changes recognized in other comprehensive income, contract assets, lease receivables, loan commitments, and financial guarantee contracts. For notes receivable, accounts receivable, receivables financing, and contract assets, the Company measures loss provisions based on expected credit losses over the entire duration, regardless of the presence of significant financing components.
For notes receivable, accounts receivable, other receivables, receivables financing, contract assets, and long-term receivables that show objective evidence of impairment, individual impairment tests are conducted to confirm expected credit losses and recognize individual impairment provisions. For those without objective evidence of impairment, the Company groups these assets based on credit risk characteristics and calculates expected credit losses on a portfolio basis.